Biofrontera Inc. (NASDAQ: BFRI)
$1.19
+0.1200 ( +11.21% ) 160.8K
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.
Market Data
Open
$1.19
Previous close
$1.07
Volume
160.8K
Market cap
$6.06M
Day range
$1.08 - $1.19
52 week range
$0.61 - $12.99
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 18 | Jun 24, 2024 |
8-k | 8K-related | 15 | Jun 14, 2024 |
4 | Insider transactions | 1 | May 22, 2024 |
8-k | 8K-related | 14 | May 22, 2024 |
10-q | Quarterly Reports | 90 | May 15, 2024 |
8-k | 8K-related | 15 | May 15, 2024 |
8-k | 8K-related | 15 | May 03, 2024 |
8-k | 8K-related | 16 | Apr 30, 2024 |
8-k | 8K-related | 14 | Apr 25, 2024 |
def | Proxies and info statements | 7 | Apr 17, 2024 |